In developed countries, bladder cancer is the fourth most frequent cancer in men and the ninth in women, and it greatly challenges patient management and cost containment. However, it is under-represented in public awareness and in cancer research.
There is little evidence on respiratory support with extracorporeal systems – enough of an argument for most of those doubting the procedure not to use it, or even make it available.
Current trends in the medical tourism industry indicate that the needs of international patients are challenging health service providers to come up with advanced solutions for quality healthcare outcomes.
A high unemployment rate coupled with an influx of refugees from Iraq and Syria has compounded challenges faced by the Jordanian government to provide healthcare for all, states a new report by healthcare experts GlobalData.
‘We aim to develop an understanding of which novel research activities could bring benefits for patients,’ explained Professor Christof von Kalle, Director of the Department of Translational Oncology, NCT (German National Centre for Tumour Diseases) and the German Cancer Research Centre (DKFZ), speaking on translational activities during the New Cancer Targets gathering in Heidelberg this…
A prototype for proton and ion therapy has been used clinically in Heidelberg since 2009. Built jointly by Siemens and GSI (Helmholtz Centre for Heavy Ion Research) in Darmstadt.
Patients with a migration background can create underestimated difficulties in healthcare systems in Western countries.
European doctors and scientists are working on the StrokeBack project, a medical system aimed at supporting stroke patients in their rehabilitation. Modern technology helps affected patients to practise their mobility at home.
IBA Group, a leader in advanced cancer diagnosis and therapy technologies, and Royal Philips Electronics (NYSE: PHG, AEX: PHI) today announced their first-ever installation of a state-of-the-art, patient-centered proton therapy treatment room in the United States.
EH Paris correspondent Annick Chapoy, reports on a French study that confirms the relevance of a drug with a long history in the management of other diseases
The world’s first gene cancer therapy study of an innovative oral vaccine is underway at the Surgical Clinic of Heidelberg University Hospital.
The list of post-operative complications is long. Most common are fever, chest infection, pneumonia, wound infection, bleeding or deep vein thrombosis. As these post-surgical complications can range from minor, self-limiting problems to major life-threatening events, their definition and severity staging can be challenging.
Using a mathematical formula that carefully measures the degree to which HIV infection of immune system cells is stalled by antiretroviral therapy, AIDS experts at Johns Hopkins have calculated precisely how well dozens of such anti-HIV drugs work, alone or in any of 857 likely combinations, in suppressing the virus.
Currently there is a truly enormous hole in the ground in the city of Wiener Neustadt, Austria, but by summer 2012 MedAustron, one of the most modern centres for ion therapy and research in Europe, is to be built here.
PBT uses a high-energy beam of particles to destroy cancer cells by more accurately targeting the affected areas and is particularly suitable for complex childhood cancers. It also increases success rates and reduces side effects, such as deafness, loss of IQ and secondary cancers.
‘Epilepsy In Our Time’, a video diary, explores life with epilepsy from the perspective of those living with the condition on European Epilepsy Day 2012. The disease is the most common serious brain disorder worldwide, affecting 6 million people in Europe.
The patient is soothed and ready for proton therapy
Susanne Werner reports on the views and revelations of international researchers gathered to deliberate the future potential of reprogrammed human adult stem cells and personalised medical treatments
Health-promoting laughter… As our year ends amid depressing global economic uncertainty, budget and staff cutbacks, threats to healthcare workers’ pensions and much else, some events shine brightly through, writes EH Editor Brenda Marsh. ‘These confirm that vision, courage and laughter can indeed cure many ills’
The European Research Council (ERC) has earmarked about €2.5 mio. to fund the research being conducted by gastroenterologist and biochemist Professor Dr. Dr. Detlef Schuppan at Mainz University Medical Center. Professor Schuppan is a specialist in liver diseases ranging from fibrosis to cirrhosis (the terminal stage of fibrosis) to hepatic cancer.
Embolisation – the blocking of vessels - is a key procedure in Interventional Radiology. It plays a steadily growing role in the treatment of various tumour lesions, with hepatic cellular carcinoma and uterine fibroids the main focus.
Point of care technologies (POCT) have an important, quality enhancing, risk-reducing and cost-impacting role within the extremely time-critical medical decision structures of a central Accident and Emergency department, says Professor Wilfried von Eiff, Centre for Hospital Management, University of Muenster, Germany.
Participants at European Health Forum Gastein 2011 (EHFG) agreed: the tendency in Germany and Austria is to operate far too soon (particularly for hip, knee and disc surgery), and many surgical interventions are unnecessary, posing a particular and increasingly urgent problem especially in industrialised countries. Hans-Christian Pruszinsky reports
From guidelines to daily clinical practice: Cardiac resynchronisation therapy is increasingly important in heart failure treatment. The therapy is complex, the demands to medical technology high. Holger Zorn reports
